Friday, March 4, 2022 Toronto, ON – Today, the Ontario government made an exciting announcement that will provide better access for Ontarians with type 1 diabetes (T1D) to continuous glucose […]
Wednesday February 2, 2022 – JDRF Canada is excited to share that the Alberta government has announced that they will provide public coverage for continuous glucose monitoring (CGM) systems for […]
We’ve received many questions about the COVID-19 vaccination rollout in provinces and territories across Canada, and specifically at what stage people living with type 1 diabetes (T1D) should expect to receive theirs.
Update: May 3, 2021: Ontario: As of May 10, 2021 anyone over 16 with type 1 diabetes can book a vaccine throughout the province. Alberta: Children aged 12 -15 with type 1 […]
The pace of type 1 diabetes (T1D) research is moving faster than ever before. In November 2021 to mark November’s National Diabetes Awareness Month, JDRF announced a new investment of $7 million to support four Canadian research […]
New research finds that ustekinumab, a drug commonly used to treat psoriasis, may help children and adolescents with type 1 diabetes keep making insulin for longer. Results from a clinical […]
This past spring, the province committed to providing public coverage for advanced glucose monitors, including continuous glucose monitoring (CGM) and flash glucose monitoring (Flash GM) for people with T1D up […]
These awards support the career development of the next generation of health researchers. The REDI awards are available to post-doctoral researchers, clinicians, and research associates from specific underrepresented groups to […]
Wednesday, April 7, 2021, Toronto, ON – “JDRF Canada applauds this week’s provincial government announcements out of Saskatchewan and Manitoba, which are expanding access to insulin pumps and continuous and flash […]
JDRF Canada is thrilled to continue a successful partnership with the Canadian Islet Research and Training Network (CIRTN) and announce a second cohort of co-funded trainees beginning in 2024. CIRTN […]
Toronto, Ontario, February 20, 2024 – JDRF Canada and Sanofi Canada are announcing a partnership aimed at amplifying awareness around type 1 diabetes (T1D), a chronic autoimmune condition, and the […]
A recent increase in type 1 diabetes (T1D) diagnoses in children under 18 in some hospitals in north-west London, UK, has triggered news stories that COVID-19 could cause the disease in children. But experts have stressed that the locally reported increase in diagnoses is not yet clearly linked to the pandemic.
